Skip to main content
. 2020 Jul 27;10:12462. doi: 10.1038/s41598-020-69330-2

Figure 7.

Figure 7

Model comparison and clinical usefulness of IRGs nomogram. Decision curve analysis of the nomogram model in TCGA 3-year (a) and 5-year (b) prediction and GEO 3-year (c) and 5-year (d) prediction. The clinical usefulness of IRGs nomogram model and the stage evaluation system were compared to treating none or all of the patients. The higher the net benefit, the better the evaluation model was. In both training and validation sets, using the IRGs nomogram to predict patient prognosis added more benefit than treating none or all patients, and was more beneficial compared to using the stage evaluation to predict.